药物发现,开发和制造 499条(本栏目收费,不能显示细节,电话15274084725)
METHOD DEVELOPMENT FOR
PRECLINICAL BIOANALYTICAL
SUPPORT 1491
ANALYTICAL CHEMISTRY METHODS:
DEVELOPMENTS AND VALIDATION 1525
CHEMICAL AND PHYSICAL
CHARACTERIZATIONS OF
POTENTIAL NEW CHEMICAL ENTITY 1585
PERMEABILITY ASSESSMENT 1601
HOW AND WHERE ARE DRUGS
ABSORBED? 1623
ABSORPTION OF DRUGS AFTER
ORAL ADMINISTRATION 1655
DISTRIBUTION: MOVEMENT OF
DRUGS THROUGH THE BODY 1697
THE BLOOD – BRAIN BARRIER AND
ITS EFFECT ON ABSORPTION
AND DISTRIBUTION 1727
TRANSPORTER INTERACTIONS IN
THE ADME PATHWAY OF DRUGS 1781
ACCUMULATION OF DRUGS
IN TISSUES 1803
SALT AND COCRYSTAL FORM
SELECTION 1829
STABILITY: PHYSICAL AND
CHEMICAL 1919
CYTOCHROME P450 ENZYMES 2001
IN VITRO METABOLISM IN
PRECLINICAL DRUG DEVELOPMENT 2117
UTILIZATION OF IN VITRO
CYTOCHROME P450 INHIBITION
DATA FOR PROJECTING CLINICAL
DRUG – DRUG INTERACTIONS 2149
IN VIVO METABOLISM IN
PRECLINICAL DRUG DEVELOPMENT 2203
IN VITRO EVALUATION OF
METABOLIC DRUG – DRUG
INTERACTIONS: SCIENTIFIC
CONCEPTS AND PRACTICAL
CONSIDERATIONS 2227
MECHANISMS AND CONSEQUENCES
OF DRUG – DRUG INTERACTIONS 2253
SPECIES COMPARISON OF
METABOLISM IN MICROSOMES
AND HEPATOCYTES 2293
METABOLITE PROFILING AND
STRUCTURAL IDENTIFICATION 2311
LINKAGE BETWEEN
TOXICOLOGY OF DRUGS AND
METABOLISM 2349
INTERRELATIONSHIP BETWEEN
PHARMACOKINETICS AND
METABOLISM 2411
EXPERIMENTAL DESIGN
CONSIDERATIONS IN
PHARMACOKINETIC STUDIES 2433
BIOAVAILABILITY AND
BIOEQUIVALENCE STUDIES 2443
MASS BALANCE STUDIES 2477